WILMINGTON, Del. - The chief liquidation officer in the Chapter 11 bankruptcy of Savient Pharmaceuticals Inc. on May 15 filed a declaration in the U.S. Bankruptcy Court for the District of Delaware contending that the company's plan of liquidation should be approved because it satisfies all requirements for confirmation under the Bankruptcy Code (In Re: Savient Pharmaceuticals Inc., No. 13-12680, Chapter 11, D. Del. Bkcy.).